keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) serves both as a substrate-specific peptide inhibitor of MLCK and as an inhibitor of hypotonicity-induced Ca2+ entry. This compound has applications in the research of human cervical cancer [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) serves both as a substrate-specific peptide inhibitor of MLCK and as an inhibitor of hypotonicity-induced Ca2+ entry. This compound has applications in the research of human cervical cancer [1] [2]. |
In vitro | Myosin light chain kinase fragment 11-19 amide (5 μM) diminishes the amplitude and activation kinetics of noradrenaline-induced non-selective cation current (I_cat) in rabbit portal vein myocytes [1]. |
Synonyms | MLCK(11-19) amide |
Molecular Weight | 987.16 |
Formula | C40H78N18O11 |
CAS No. | 119386-39-9 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Myosin light chain kinase fragment 11-19 amide 119386-39-9 MLCK(11-19) amide inhibitor inhibit